| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/15/2002 | WO2002045800A3 Liquid composition comprising an alcohol |
| 08/15/2002 | WO2002044175A3 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 08/15/2002 | WO2002042429A3 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 08/15/2002 | WO2002042266A3 Process for the production of ceftifur sodium salt |
| 08/15/2002 | WO2002042265A3 Cyanoguanidine prodrugs |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002034266A9 Method for inhibiting cataracts |
| 08/15/2002 | WO2002032915B1 Combinatorial libraries of monosaccharides |
| 08/15/2002 | WO2002032861A3 Orally active salts with tyrosine kinase activity |
| 08/15/2002 | WO2002032459A3 Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
| 08/15/2002 | WO2002032419A3 Methods for modulating bladder function |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin |
| 08/15/2002 | WO2002028821A3 Propionic acid derivatives with ppar-alpha activating properties |
| 08/15/2002 | WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 08/15/2002 | WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/15/2002 | WO2002026249A3 Methods for inhibition of viral infection |
| 08/15/2002 | WO2002024609A3 Method for producing a radioprotector |
| 08/15/2002 | WO2002022160A3 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 08/15/2002 | WO2002019966A3 Cardiac arrhythmia treatment methods |
| 08/15/2002 | WO2002019961A3 Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | WO2002017901A3 Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma |
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | WO2002015938A3 Testosterone ester formulation for human use |
| 08/15/2002 | WO2002013793A3 Method of making tablets and tablet compositions produced therefrom |
| 08/15/2002 | WO2002011731A3 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches |
| 08/15/2002 | WO2002011724A3 Neuroprotective 2-pyridinamine compositions and related methods |
| 08/15/2002 | WO2002008446A3 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 08/15/2002 | WO2002005870A3 Kits and compositions supporting intracranial perfusions |
| 08/15/2002 | WO2002003815A3 Composition for the treatment of migraine |
| 08/15/2002 | WO2002000263A3 Tripeptide prodrug compounds |
| 08/15/2002 | WO2002000195A3 Methods and compositions for treating pain of the mucous membrane |
| 08/15/2002 | WO2002000175A3 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 08/15/2002 | WO2001096307A3 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 08/15/2002 | WO2001095945A3 Prodrug compounds cleavable by thimet oligopeptidase |
| 08/15/2002 | WO2001091764A3 Extracts from spermatophyte plants with immunomodulating activity |
| 08/15/2002 | WO2001091763A3 Extracts from spermatophyte plants with antitumor activity |
| 08/15/2002 | WO2001084961A3 Preparation for the prevention and/or treatment of vascular disorders |
| 08/15/2002 | WO2001080843A3 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same |
| 08/15/2002 | WO2001079246A3 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 08/15/2002 | WO2001072685B1 Polyamine analogues as cytotoxic agents |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001064899A3 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 08/15/2002 | WO2001061039A3 5-hydroxytryptamine transporter gene polymorphisms |
| 08/15/2002 | WO2001040309A9 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 08/15/2002 | WO2001039765A9 Compositions and methods for the induction and treatment of retinal detachments |
| 08/15/2002 | WO2001030768A9 Methods and compositions utilizing quinazolinones |
| 08/15/2002 | WO2001028545A9 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 08/15/2002 | WO2001027135A9 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO2001013935A3 Modulation of the blood-brain barrier transporter for leptin |
| 08/15/2002 | US20020111679 Apparatus and method for determining implant size |
| 08/15/2002 | US20020111657 Method of controlling body temperature while reducing shivering |
| 08/15/2002 | US20020111590 Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
| 08/15/2002 | US20020111505 Purified 15-epi-lipoxin compound has a longer tissue half-life; anticancer agents |
| 08/15/2002 | US20020111502 Cholic acid or deoxycholic acid derivatives can include polypeptides, polynucleotides such as genes and antisense nucleic acids that can modulate cellular activity |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111488 Beta-substitued beta-aminoethyl phosphonate derivatives |
| 08/15/2002 | US20020111486 Exhibits affinity for monoamine transporters useful in diagnosis of parkinson's disease |
| 08/15/2002 | US20020111483 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
| 08/15/2002 | US20020111469 Polypeptide for use in the treatment of tumors, lung defects, inflammation and heart defects |
| 08/15/2002 | US20020111392 Biodegradation; insertion into body, crosslinking |
| 08/15/2002 | US20020111384 Administering levodopa, or mixture thereof |
| 08/15/2002 | US20020111383 Ultrafine L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 08/15/2002 | US20020111382 Antiviral compounds and method of treating viral infections |
| 08/15/2002 | US20020111381 Vision disorders; topical applying |
| 08/15/2002 | US20020111379 Methods of treating anxiety disorders |
| 08/15/2002 | US20020111378 Inhibitors of IMPDH enzyme |
| 08/15/2002 | US20020111377 Transdermal delivery of cannabinoids |
| 08/15/2002 | US20020111375 Antitumor agents |
| 08/15/2002 | US20020111374 Estrogen receptor modulators |
| 08/15/2002 | US20020111373 Thiadiazolidin-2,4-dione compound |
| 08/15/2002 | US20020111371 Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke |
| 08/15/2002 | US20020111370 Compounds useful as antibacterial agents |
| 08/15/2002 | US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/15/2002 | US20020111367 Phenyl substituted pyridine and benzene derivatives |
| 08/15/2002 | US20020111366 Therapy for brain disorders; strokes |
| 08/15/2002 | US20020111365 Administering protease inhibitor |
| 08/15/2002 | US20020111364 ABCA-1 elevating compounds |
| 08/15/2002 | US20020111363 Antihistamines; atomizing |
| 08/15/2002 | US20020111362 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same |
| 08/15/2002 | US20020111360 Quinazoline formulations and therapeutic use thereof |
| 08/15/2002 | US20020111359 Side effect reduction of narcotics |
| 08/15/2002 | US20020111357 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 08/15/2002 | US20020111356 Phosphodiesterase inhibitor; antiinflammatory agents |
| 08/15/2002 | US20020111355 Antitumor agents; contraceptives |
| 08/15/2002 | US20020111354 Novel heteroary1 derivatives and their use as medicaments |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111352 Parasiticides |
| 08/15/2002 | US20020111351 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
| 08/15/2002 | US20020111350 Aryl fused azapolycyclic compounds |
| 08/15/2002 | US20020111349 Method for treatment and prevention of mastitis |
| 08/15/2002 | US20020111347 Nervous system disorders |
| 08/15/2002 | US20020111346 Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
| 08/15/2002 | US20020111345 Use of taurolidine to treat tumors |
| 08/15/2002 | US20020111343 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-Amyloid peptide release and/or its synthesis by use of such compounds |
| 08/15/2002 | US20020111342 Methods for the inhibition of egg production in trematodes |
| 08/15/2002 | US20020111341 Bicyclic amino-pyrazinone compounds |